BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 35040086)

  • 1. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
    Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulation as a consequence of SARS-CoV-2 infection.
    Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
    Front Immunol; 2022; 13():954391. PubMed ID: 36110850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic meta-analysis of immune signatures in patients with COVID-19.
    Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
    Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
    Mulchandani R; Lyngdoh T; Kakkar AK
    Eur J Clin Invest; 2021 Jan; 51(1):e13429. PubMed ID: 33058143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
    Li Q; Xu W; Li WX; Huang CL; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis.
    Zhang Z; Ai G; Chen L; Liu S; Gong C; Zhu X; Zhang C; Qin H; Hu J; Huang J
    BMC Infect Dis; 2021 Aug; 21(1):738. PubMed ID: 34344353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
    Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
    Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
    Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
    Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.
    Luo M; Liu J; Jiang W; Yue S; Liu H; Wei S
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32544099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
    Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients.
    González-Cuadrado C; Caro-Espada PJ; Chivite-Lacaba M; Utrero-Rico A; Lozano-Yuste C; Gutierrez-Solis E; Morales E; Sandino-Pérez J; Gil-Etayo FJ; Allende-Martínez L; Laguna-Goya R; Paz-Artal E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.